The Blood Based Biomarkers Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Blood Based Biomarkers Market?
The market size for blood-based biomarkers has experienced substantial growth in recent times. It is forecasted to rise from $23.13 billion in 2024 to $26.06 billion in 2025, with a compound annual growth rate (CAGR) of 12.6%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Blood Based Biomarkers Industry?
The Blood Based Biomarkers Global Market is predicted to reach a size of $41.55 billion by the year 2029. This features a growth rate of 12.4% Compound Annual Growth Rate (CAGR).
Download Your Free Sample of the 2025 Blood Based Biomarkers Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Blood Based Biomarkers Market?
The key drivers in the blood based biomarkers market are:
• Expansion of AI and machine learning in biomarker analysis
• Increased demand for early disease detection
• The growth of telemedicine and remote diagnostics
• Rising prevalence of chronic diseases and increased consumer health awareness
Global Market Segmentation: Identifying Major Blood Based Biomarkers Industry Segments
The blood based biomarkers market covered in this report is segmented –
1) By Type: Genetic Biomarkers, Protein Biomarkers, Metabolic Biomarkers, Cell-Based Biomarkers, Epigenetic Biomarkers
2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Immunoassays, Mass Spectrometry, Other Technologies
3) By Application: Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, Other Applications
4) By End Users: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End Users
Pre-order the 2025 Blood Based Biomarkers Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Blood Based Biomarkers Market?
The key trends in the blood based biomarkers market are:
• The integration of AI and machine learning in biomarker analysis is one of the significant emerging trends.
• There is an increasing trend for early disease detection.
• Advancements in liquid biopsy and the rise of telemedicine and remote diagnostics are shaping the future of the market.
• The emergence of point-of-care (POC) testing devices and innovations in next-generation sequencing (NGS) are also major trends.
Who Are the Top Competitors & Leading Players in the Blood Based Biomarkers Market?
Major players in the blood based biomarkers market are:
• Siemens Healthineers AG
• Agilent Technologies Inc
• Eisai Co Ltd
• Sysmex Corporation
• Exact Sciences Corporation
• Guardant Health
• Quanterix Corporation
• Illumina Inc
• QIAGEN NV
• GENFIT
• Foundation Medicine Inc
• Adaptive Biotechnologies Corporation
• GRAIL LLC
• Biodesix Inc
• Cleveland Diagnostics Inc
• Creative Diagnostics
• Epigenomics AG
• C2N Diagnostics
• Diadem srl
• Proteomedix AG
Regional Dominance: Which Area Leads the Global Blood Based Biomarkers Market?
North America was the largest region in the blood-based biomarkers market in 2024
